Evidence map›Paper›PMID 27215193›Full record

ArticleActa neuropathologica communications2016

Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia.

Kevin C Kemp, Amelia J Cook, Juliana Redondo, Kathreena M Kurian, Neil J Scolding, Alastair Wilkins

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Beyond synapses: cytoplasmic connections in brain function and evolution.Biological reviews of the Cambridge Philosophical Society · 2025
    Review
  10. Divergent somatic mutation patterns among human cerebellar neuron types.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Friedreich ataxia: clinical features and new developments.Neurodegenerative disease management · 2022
    Review
  17. Neuroinflammation in Friedreich's Ataxia.International journal of molecular sciences · 2022
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kevin C KempMultiple Sclerosis and Stem Cell Group, Clinical Neurosciences office, University of Bristol, 1st floor, Learning and Research building, Southmead Hospital, Bristol, BS10 5NB, UK. kevin.kemp@bristol.ac.uk.
Amelia J CookMultiple Sclerosis and Stem Cell Group, Clinical Neurosciences office, University of Bristol, 1st floor, Learning and Research building, Southmead Hospital, Bristol, BS10 5NB, UK.
Juliana RedondoMultiple Sclerosis and Stem Cell Group, Clinical Neurosciences office, University of Bristol, 1st floor, Learning and Research building, Southmead Hospital, Bristol, BS10 5NB, UK.
Kathreena M KurianBrain Tumour research group, School of Clinical Sciences, University of Bristol, Bristol, BS10 5NB, UK.
Neil J ScoldingMultiple Sclerosis and Stem Cell Group, Clinical Neurosciences office, University of Bristol, 1st floor, Learning and Research building, Southmead Hospital, Bristol, BS10 5NB, UK.
Alastair WilkinsMultiple Sclerosis and Stem Cell Group, Clinical Neurosciences office, University of Bristol, 1st floor, Learning and Research building, Southmead Hospital, Bristol, BS10 5NB, UK.
University of Bristol · GBSouthmead Hospital · GB

Funding

Medical Research Council G0701018Medical Research Council G1100578Medical Research Council MR/J012580/1Medical Research Council MR/K004166/1Medical Research Council MR/N004272/1
6 · The paper itself

Abstract

Purkinje cell pathology is a common finding in a range of inherited and acquired cerebellar disorders, with the degree of Purkinje cell injury dependent on the underlying aetiology. Purkinje cells have an unparalleled resistance to insult and display unique regenerative capabilities within the central nervous system. Their response to cell injury is not typical of most neurons and likely represents both degenerative, compensatory and regenerative mechanisms. Here we present a pathological study showing novel and fundamental insights into Purkinje cell injury, remodelling and repair in Friedreich's ataxia; the most common inherited ataxia. Analysing post-mortem cerebellum tissue from patients who had Friedreich's ataxia, we provide evidence of significant injury to the Purkinje cell axonal compartment with relative preservation of both the perikaryon and its extensive dendritic arborisation. Axonal remodelling of Purkinje cells was clearly elevated in the disease. For the first time in a genetic condition, we have also shown a disease-related increase in the frequency of Purkinje cell fusion and heterokaryon formation in Friedreich's ataxia cases; with evidence that underlying levels of cerebellar inflammation influence heterokaryon formation. Our results together further demonstrate the Purkinje cell's unique plasticity and regenerative potential. Elucidating the biological mechanisms behind these phenomena could have significant clinical implications for manipulating neuronal repair in response to neurological injury.

Indexed as

AdultAgedAged, 80 and overAxonsCohort StudiesFemaleFriedreich AtaxiaHumansImaging, Three-DimensionalImmunohistochemistryMaleMicrogliaMicroscopy, ConfocalMiddle AgedMyelin SheathNeuroimmunomodulationCerebellumFriedreich’s ataxiaFusionHeterokaryonNeurodegenerationPurkinje cell

Identifiers

PMID27215193
PMCPMC4877974
OpenAlexW2397043734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.